β-Strand Mimicking Macrocyclic Amino Acids: Templates for Protease Inhibitors with Antiviral Activity
- 12 December 2001
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 45 (2) , 371-381
- https://doi.org/10.1021/jm010414i
Abstract
New amino acids are reported in which component macrocycles are constrained to mimic tripeptides locked in a beta-strand conformation. The novel amino acids involve macrocycles functionalized with both an N- and a C-terminus enabling addition of appendages at either end to modify receptor affinity, selectivity, or membrane permeability. We show that the cycles herein are effective templates within inhibitors of HIV-1 protease. Eleven compounds originating from such bifunctionalized cyclic templates are potent inhibitors of HIV-1 protease (Ki 0.3-50 nM; pH 6.5, I = 0.1 M). Unlike normal peptides comprising amino acids, five of these macrocycle-containing compounds are potent antiviral agents with sub-micromolar potencies (IC(50) 170-900 nM) against HIV-1 replication in human MT2 cells. The most active antiviral agents are the most lipophilic, with calculated values of LogD(6.5) > or = 4. All molecules have a conformationally constrained 17-membered macrocyclic ring that has been shown to structurally mimic a tripeptide segment (Xaa)-(Val/Ile)-(Phe/Tyr) of a peptide substrate in the extended conformation. The presence of two trans amide bonds and a para-substituted aromatic ring prevents intramolecular hydrogen bonds and fixes the macrocycle in the extended conformation. Similarly constrained macrocycles may be useful templates for the creation of inhibitors for the many other proteins and proteases that recognize peptide beta-strands.Keywords
This publication has 16 references indexed in Scilit:
- High-throughput x-ray crystallography for structure-based drug designDrug Discovery Today, 2001
- Approaches to the Design of Effective HIV-1 Protease InhibitorsCurrent Medicinal Chemistry, 2000
- Conformational Selection of Inhibitors and Substrates by Proteolytic Enzymes: Implications for Drug Design and Polypeptide ProcessingJournal of Medicinal Chemistry, 2000
- Protease Inhibitors: Current Status and Future ProspectsJournal of Medicinal Chemistry, 2000
- INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug DesignAnnual Review of Biophysics, 1998
- Molecular Recognition of Protein−Ligand Complexes: Applications to Drug DesignChemical Reviews, 1997
- Structure-activity relationships for macrocyclic peptidomimetic inhibitors of HIV-1 proteaseBioorganic & Medicinal Chemistry Letters, 1996
- Substrate-Based Cyclic Peptidomimetics of Phe-Ile-Val That Inhibit HIV-1 Protease Using a Novel Enzyme-Binding ModeJournal of the American Chemical Society, 1996
- Regioselective structural and functional mimicry of peptides. Design of hydrolytically-stable cyclic peptidomimetic inhibitors of HIV-1 protease.Journal of the American Chemical Society, 1995
- Protein targets for structure-based drug designMedicinal Research Reviews, 1992